Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Novavax (NASDAQ:NVAX) was downgraded to Underperform from Neutral at Bank of America, citing growth outlook challenges despite acknowledging the company’s strong execution and recent cost-cutting ...

In the latest close session, Novavax (NVAX) was down 4.02% at $9.08. This move lagged the S&P 500's daily gain of 0.37%. At the same time, the Dow lost 0.14%, and the tech-heavy Nasdaq gained 0.71%.

Investors in Novavax, Inc. (Symbol: NVAX) saw new options become available today, for the November 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVAX ...

This was the stock's sixth consecutive day of losses.

Investors in Novavax, Inc. (Symbol: NVAX) saw new options begin trading this week, for the December 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVAX ...

Shah Capital is reportedly pressing Novavax Inc. (NASDAQ:NVAX) to consider a sale of the biotech firm, citing continued struggles in the rollout of its COVID-19 vaccine. • NVAX stock is showing ...

This was the stock's fifth consecutive day of losses.